End-of-day quote
Shanghai S.E.
06:00:00 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
33.46
CNY
|
+0.84%
|
|
-3.32%
|
+48.91%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,975
|
4,306
|
3,783
|
2,426
|
4,161
|
6,754
|
-
|
Enterprise Value (EV)
1 |
4,975
|
4,306
|
3,783
|
2,426
|
4,161
|
6,754
|
6,754
|
P/E ratio
|
43.7
x
|
33.6
x
|
45.1
x
|
81.9
x
|
250
x
|
69.7
x
|
49.2
x
|
Yield
|
0.79%
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
13.4
x
|
8.92
x
|
-
|
-
|
8.34
x
|
8.85
x
|
6.75
x
|
EV / Revenue
|
13.4
x
|
8.92
x
|
-
|
-
|
8.34
x
|
8.85
x
|
6.75
x
|
EV / EBITDA
|
35.7
x
|
32.2
x
|
-
|
-
|
103
x
|
44.1
x
|
32.9
x
|
EV / FCF
|
-
|
41,570,281
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
5.98
x
|
4.2
x
|
-
|
-
|
4.17
x
|
5.39
x
|
4.86
x
|
Nbr of stocks (in thousands)
|
183,352
|
186,621
|
186,554
|
185,186
|
185,190
|
201,842
|
-
|
Reference price
2 |
27.14
|
23.07
|
20.28
|
13.10
|
22.47
|
33.46
|
33.46
|
Announcement Date
|
3/27/20
|
3/4/21
|
4/19/22
|
3/22/23
|
4/17/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
371.3
|
482.6
|
-
|
-
|
499
|
763
|
1,000
|
EBITDA
1 |
139.2
|
133.8
|
-
|
-
|
40.59
|
153
|
205
|
EBIT
1 |
123.8
|
125.1
|
-
|
-
|
15.68
|
118
|
168
|
Operating Margin
|
33.35%
|
25.92%
|
-
|
-
|
3.14%
|
15.47%
|
16.8%
|
Earnings before Tax (EBT)
1 |
125.8
|
125.2
|
-
|
-
|
15.34
|
118
|
168
|
Net income
1 |
114.2
|
128.3
|
83.11
|
29.32
|
17.48
|
89
|
126
|
Net margin
|
30.77%
|
26.58%
|
-
|
-
|
3.5%
|
11.66%
|
12.6%
|
EPS
2 |
0.6214
|
0.6857
|
0.4500
|
0.1600
|
0.0900
|
0.4800
|
0.6800
|
Free Cash Flow
|
-
|
103.6
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
21.46%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
77.4%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
80.73%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.2143
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/20
|
3/4/21
|
4/19/22
|
3/22/23
|
4/17/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
104
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
14.5%
|
14%
|
-
|
-
|
1.67%
|
7.7%
|
9.9%
|
ROA (Net income/ Total Assets)
|
13.1%
|
11%
|
-
|
-
|
-
|
5.3%
|
6.7%
|
Assets
1 |
874.8
|
1,164
|
-
|
-
|
-
|
1,679
|
1,881
|
Book Value Per Share
2 |
4.540
|
5.500
|
-
|
-
|
5.390
|
6.210
|
6.890
|
Cash Flow per Share
2 |
0.0700
|
0.7700
|
-
|
-
|
0.6500
|
-0.3000
|
-0.0700
|
Capex
1 |
132
|
41
|
-
|
-
|
3.63
|
103
|
90
|
Capex / Sales
|
35.64%
|
8.5%
|
-
|
-
|
0.73%
|
13.5%
|
9%
|
Announcement Date
|
3/27/20
|
3/4/21
|
4/19/22
|
3/22/23
|
4/17/24
|
-
|
-
|
Last Close Price
33.46
CNY Average target price
33.67
CNY Spread / Average Target +0.63% Consensus |
1st Jan change
|
Capi.
|
---|
| +48.91% | 927M | | +10.85% | 34.67B | | +24.06% | 8.27B | | +11.40% | 7.96B | | +28.08% | 5.71B | | +42.66% | 4.19B | | -3.15% | 4.08B | | +11.10% | 3.62B | | +8.96% | 3.54B | | -4.77% | 2.82B |
Testing & Measuring Equipment
|